Gaurav Shah, CEO, Director at Rocket Pharmaceuticals, holds 1.12M shares in Rocket Pharmaceuticals (Ticker: RCKT), holds ― shares in Tourmaline Bio (Ticker: TRML). Most recently, Gaurav Shah Sold ― shares of Rocket Pharmaceuticals on Aug 20, 2024 for an estimated value of 178.53K.
What is the percentage of profitable transactions made by Gaurav Shah?
The percentage of profitable transactions made by Gaurav Shah is 50%.
What is the average return per transaction made by Gaurav Shah?
The average return per transaction made by Gaurav Shah is -2.80%.
What stocks does Gaurav Shah hold?
Gaurav Shah holds: RCKT, TRML stocks.
What was Gaurav Shah’s latest transaction?
Gaurav Shah latest transaction was an Informative Sell of $178.53K.
What was Gaurav Shah's most profitable transaction?
Gaurav Shah’s most profitable transaction was an Informative Sell of RCKT stock on February 21, 2024. The return on the trade was 38.80%.
What is Gaurav Shah's role in Rocket Pharmaceuticals?
Gaurav Shah's role in Rocket Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.